Lonza has entered a strategic partnership with Novartis for the scale up development and production of its pipeline of biotechnology drugs. Under the long-term partnership each product will have a specific development agreement. Lonza will provide process development and manufacturing capabilities from its R&D centre in Slough, UK, and manufacturing capacity in the US, Spain and Singapore.
Smart Money
Sunday, 13 July 2008
Lonza in development deal with Novartis
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment